Author

Robert A. Blum

Observed names: R A Blum, R BLUM, R Blum, R. Blum, R.A. Blum, Robert A Blum, Robert Blum

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), DuPont (United States), Kaleida Health, Thomas Jefferson University, University of Freiburg, Pfizer (United States), Virginia Commonwealth University, University Medical Center Freiburg, University of Illinois Chicago, Millard Fillmore Suburban Hospital, GlaxoSmithKline (United States), University at Buffalo, State University of New York

OpenAlex ID: A5111914294

Vancomycin pharmacokinetics in patients with various degrees of renal function

1988 · K A Rodvold, R A Blum, et al. · Antimicrobial Agents and Chemotherapy · 251

Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP‐4 Inhibitor Sitagliptin in Middle‐Aged Obese Subjects

2006 · Gary A. Herman, Arthur Bergman, et al. · The Journal of Clinical Pharmacology · 188

Increased Gastric pH and the Bioavailability of Fluconazole and Ketoconazole

1991 · Robert A. Blum, David T. D'Andrea, et al. · Annals of Internal Medicine · 167

Dose Equivalency Evaluation of Major Corticosteroids: Pharmacokinetics and Cell Trafficking and Cortisol Dynamics

2003 · Donald E. Mager, Sheren X. Lin, et al. · The Journal of Clinical Pharmacology · 166

Pharmacokinetics of gabapentin in subjects with various degrees of renal function

1994 · Robert A Blum, Thomas J Comstock, et al. · Clinical Pharmacology & Therapeutics · 151

Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients

1995 · Michael R. Goldberg, Thomas E. Bradstreet, et al. · Hypertension · 131

Evaluation of Potential Inductive Effects of Aprepitant on Cytochrome P450 3A4 and 2C9 Activity

2004 · Craig R. Shadle, Yih Lee, et al. · The Journal of Clinical Pharmacology · 126

Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race

2001 · Mindy He Magee, Robert A. Blum, et al. · The Journal of Clinical Pharmacology · 126

Effect of fluconazole on the disposition of phenytoin

1991 · Robert A Blum, John H Wilton, et al. · Clinical Pharmacology & Therapeutics · 119

Pharmacokinetic Drug Interactions Between Clobazam and Drugs Metabolized by Cytochrome P450 Isoenzymes

2012 · Mark Walzer, Ihor Bekersky, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 90

Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects

2003 · Robert A. Blum, Anup Majumdar, et al. · Clinical Therapeutics · 87

Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers*

1997 · David J. Kazierad, David E. Martin, et al. · Clinical Pharmacology & Therapeutics · 86

Pharmacokinetics of Rosiglitazone in Patients with Varying Degrees of Renal Insufficiency

2003 · Martha C. Chapelsky, Kathleen Thompson‐Culkin, et al. · The Journal of Clinical Pharmacology · 78

The effect of renal disease on the disposition of venlafaxine

1994 · Steven M Troy, Robert W Schultz, et al. · Clinical Pharmacology & Therapeutics · 77

Safety and Pharmacokinetics of Bevirimat (PA-457), a Novel Inhibitor of Human Immunodeficiency Virus Maturation, in Healthy Volunteers

2007 · David E. Martin, Robert Blum, et al. · Antimicrobial Agents and Chemotherapy · 76

The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion

1997 · Robert A. Blum, Harry Shi, et al. · Clinical Therapeutics · 64

Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis

1989 · R A Blum, R K Kohli, et al. · Antimicrobial Agents and Chemotherapy · 62

Multiple-Dose Pharmacokinetics and??Safety of Bevirimat, a??Novel??Inhibitor??of??HIV Maturation,??in??Healthy??Volunteers

2007 · David E Martin, Robert Blum, et al. · Clinical Pharmacokinetics · 52

Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation

2002 · Mindy He Magee, Robert A. Blum, et al. · British Journal of Clinical Pharmacology · 44

PDF

Effects In Humans Of Intravenously Administered Endotoxin On Soluble Cell-Adhesion Molecule And Inflammatory Markers: A Model Of Human Diseases

2001 · Mf Wilson, R Blum, et al. · Clinical and Experimental Pharmacology and Physiology · 41

Central Nervous System Toxicity Associated With Meperidine Use in Hepatic Disease

1994 · Larry H. Danziger, Steven J. Martin, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 41

Lansoprazole and omeprazole in the treatment of acid peptic disorders

1996 · Robert A. Blum · American Journal of Health-System Pharmacy · 40

Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers

2002 · Brent M. Booker, Mindy He Magee, et al. · Clinical Pharmacology & Therapeutics · 36

Pharmacokinetic and Adrenal Interactions of IL‐10 and Prednisone in Healthy Volunteers

1999 · Abhijit Chakraborty, Robert A. Blum, et al. · The Journal of Clinical Pharmacology · 30

Pharmacoimmunodynamic interactions of interleukin-10 and prednisone in healthy volunteers

1999 · A CHAKRABORTY, R BLUM, et al. · Clinical Pharmacology & Therapeutics · 29

Works count: 76

Citation count: 2,902

H-index: 28

I10-index: 49